middle.news
AdAlta nears FDA advice as EW-001 reaches Australian manufacturing stage
9:45am on Monday 26th of October, 2026 AEDT
•
Biotechnology
Read Story
AdAlta nears FDA advice as EW-001 reaches Australian manufacturing stage
9:45am on Monday 26th of October, 2026 AEDT
Key Points
US FDA pre-IND meeting scheduled for 4 November 2026
First Australian EW-001 manufacturing runs expected in the second half of 2026
Complete responder passes two years without cancer recurrence
More than A$1 million in R&D Tax Incentive inflows expected
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AdAlta (ASX:1AD)
OPEN ARTICLE